Market Cap

Sosei Group Corp Market Capitalization:

¥80.27 Billion

JPY as of Jan. 1, 2026

US$512.2 Million

business Sosei Group Corp Company Profile

Sosei Group Corp Main Stock Listing

JPX: 4565

Market Capitalization History of Sosei Group Corp

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Sosei Group Corp market cap

Date Market Cap YoY Change
Jan. 1, 2026 ¥80.27 B -13.65%
Jan. 1, 2025 ¥92.96 B -27.66%
Jan. 1, 2024 ¥128.50 B -30.72%
Jan. 1, 2023 ¥185.47 B 43.64%
Jan. 1, 2022 ¥129.13 B -22.99%
Jan. 1, 2021 ¥167.68 B 1.97%
Jan. 1, 2020 ¥164.45 B 90.72%
Jan. 1, 2019 ¥86.23 B -65.60%
Jan. 1, 2018 ¥250.67 B -10.01%
Jan. 1, 2017 ¥278.55 B 9.08%
Jan. 1, 2016 ¥255.36 B 201.13%
Jan. 1, 2015 ¥84.80 B -0.50%
Jan. 1, 2014 ¥85.23 B 36.22%
Jan. 1, 2013 ¥62.56 B 146.44%
Jan. 1, 2012 ¥25.39 B -17.84%
Jan. 1, 2011 ¥30.90 B 55.96%
Jan. 1, 2010 ¥19.81 B 207.26%
Jan. 1, 2009 ¥6.45 B -74.75%
Jan. 1, 2008 ¥25.54 B -39.09%
Jan. 1, 2007 ¥41.92 B -45.88%
Jan. 1, 2006 ¥77.46 B -43.48%
Jan. 1, 2005 ¥137.04 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Sosei Group Corp Categories

Japan languages Healthcare languages Biotechnology
Japan Healthcare Japan Biotechnology

Stocks & Indices

Sosei Group Corp has the following listings and related stock indices.


Stock: JPX: 4565

Stock: FSX: JSS

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.